Life sciences executives believe their industry is doing a better job at managing revenue, yet nearly all continue to struggle with this business-critical function in their own organizations. What makes optimizing revenue so complicated?

Hear from our industry experts as they present key insight from the 2022 State of Revenue Report – the fourth annual survey of executives who are directly responsible for optimizing revenue at large pharmaceutical and medical technology companies. We discuss how revenue management teams are evolving to address new and ongoing challenges and opportunities. We also uncover ways that technology can have the biggest impact on operational processes and revenue growth.

Topics covered include:

• Ensuring compliance on a federal and state level
• Adapting to new business models
• Reducing the impact of staffing issues on revenue management programs
• Leveraging innovative technologies to improve data collection and management